Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center
<p>Abstract</p> <p>Background</p> <p>To evaluate the therapeutic strategies commonly employed in the clinic for the management of brain metastases (BMs) and to correlate disease outcome with type of treatment and therapeutic resources available at the treating center.&l...
Main Authors: | Pace Andrea, Mansueto Giovanni, Lanzetta Gaetano, Russillo Michelangelo, Moscetti Luca, Telera Stefano, Bria Emilio, Mirri Alessandra, Metro Giulio, Felici Alessandra, Fabi Alessandra, Maschio Marta, Vidiri Antonello, Sperduti Isabella, Cognetti Francesco, Carapella Carmine M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-01-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | http://www.jeccr.com/content/30/1/10 |
Similar Items
-
Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation
by: Mirri Maria, et al.
Published: (2009-03-01) -
Quantitative analysis of CT-perfusion parameters in the evaluation of brain gliomas and metastases
by: Di Nallo Anna, et al.
Published: (2009-03-01) -
The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine
by: Carapella Maria Carmine, et al.
Published: (2009-05-01) -
Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation
by: Vidiri Antonello, et al.
Published: (2012-04-01) -
Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy
by: Fabi Alessandra, et al.
Published: (2012-10-01)